The KRAS-variant and Second Cancer Risk
A second cancer diagnosis is often a concern of cancer patients. Although it seems unfair to have to go through the whole cancer journey again, the good news is that it is…
Read More ➝
KRAS-variant
Understanding different genetic causes of cancer: BRCA variants vs. the KRAS-variant
This post explores BRCA variants vs. the KRAS-variant and is part two of our series on understanding the different genetic causes of cancer. In part one of our series, we compared genetic…
Read More ➝
Understanding the different causes of cancer: genetic variants vs. genetic mutations
Learn more about how our genes play a role in cancer development in this two-part series comparing different genetic variants and genetic mutations. For Part 1, we’ll discuss the KRAS-variant and KRAS…
Read More ➝
Clinical Trial for Patients with the KRAS-variant and HNSCC
Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want…
Read More ➝
Important Findings From Our Recently Published KRAS-Variant Study
A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…
Read More ➝
If I participate in a study will you send me my KRAS-variant results?
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
Do I need to get tested for KRAS-variant if I’m BRCA positive?
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
KRAS-Variant and Breast Cancer
Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your…
Read More ➝
New Research: How Inherited DNA -Based Mutations Impact Immunotherapy
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
HRT and The KRAS-Variant
While there are many factors to consider before taking hormone replacement therapy (HRT), understanding your genetic profile can prove invaluable in your decision-making process. Joanne Weidhaas, MD, PhD, and her colleagues published…
Read More ➝
What You Need to Know About Estrogen and the KRAS-variant
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝
Why you should get your KRAS-variant results
Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study. While I always enjoy…
Read More ➝
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
